Widespread use of incorrect PCR ramp rate negatively impacts multidrug-resistant tuberculosis diagnosis (MTBDRplus)
dc.contributor.author | Derendinger, B. | en_ZA |
dc.contributor.author | De Vos, M. | en_ZA |
dc.contributor.author | Nathavitharana, R. R. | en_ZA |
dc.contributor.author | Dolby, T. | en_ZA |
dc.contributor.author | Simpson, J. A. | en_ZA |
dc.contributor.author | Van Helden, P. D. | en_ZA |
dc.contributor.author | Warren, Robin M. | en_ZA |
dc.contributor.author | Theron, G. | en_ZA |
dc.date.accessioned | 2018-02-27T09:34:40Z | |
dc.date.available | 2018-02-27T09:34:40Z | |
dc.date.issued | 2018 | |
dc.description | CITATION: Derendinger, B., et al. 2018. Widespread use of incorrect PCR ramp rate negatively impacts multidrug-resistant tuberculosis diagnosis (MTBDRplus). Scientific Reports, 8:3206, doi:10.1038/s41598-018-21458-y. | |
dc.description | The original publication is available at http://www.nature.com | |
dc.description | Publication of this article was funded by the Stellenbosch University Open Access Fund. | |
dc.description.abstract | ENGLISH ABSTRACT: The scale-up of rapid drug resistance testing for TB is a global priority. MTBDRplus is a WHO-endorsed multidrug-resistant (MDR)-TB PCR assay with suboptimal sensitivities and high indeterminate rates on smear-negative specimens. We hypothesised that widespread use of incorrect thermocycler ramp rate (speed of temperature change between cycles) impacts performance. A global sample of 72 laboratories was surveyed. We tested 107 sputa from Xpert MTB/RIF-positive patients and, separately, dilution series of bacilli, both at the manufacturer-recommended ramp rate (2.2 °C/s) and the most frequently reported incorrect ramp rate (4.0 °C/s). Mycobacterium tuberculosis-complex DNA (TUB-band)-detection, indeterminate results, accuracy, and inter-reader variability (dilution series only) were compared. 32 respondents did a median (IQR) of 41 (20–150) assays monthly. 78% used an incorrect ramp rate. On smear-negative sputa, 2.2 °C/s vs. 4.0 °C/s improved TUB-band positivity (42/55 vs. 32/55; p = 0.042) and indeterminate rates (1/42 vs. 5/32; p = 0.039). The actionable results (not TUB-negative or indeterminate; 41/55 vs. 28/55) hence improved by 21% (95% CI: 9–35%). Widespread use of incorrect ramp rate contributes to suboptimal MTBDRplus performance on smear-negative specimens and hence limits clinical utility. The number of diagnoses (and thus the number of smear-negative patients in whom DST is possible) will improve substantially after ramp rate correction. | en_ZA |
dc.description.uri | https://www.nature.com/articles/s41598-018-21458-y | |
dc.description.version | Publisher's version | |
dc.format.extent | 8 pages | en_ZA |
dc.identifier.citation | Derendinger, B., et al. 2018. Widespread use of incorrect PCR ramp rate negatively impacts multidrug-resistant tuberculosis diagnosis (MTBDRplus). Scientific Reports, 8:3206, doi:10.1038/s41598-018-21458-y | |
dc.identifier.issn | 2045-2322 (Online) | |
dc.identifier.other | doi:10.1038/s41598-018-21458-y | |
dc.identifier.uri | http://hdl.handle.net/10019.1/103192 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | Nature Publishing Group | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | Multidrug-resistant tuberculosis | en_ZA |
dc.subject | Tuberculosis -- Diagnosis | en_ZA |
dc.subject | Ramp rate | en_ZA |
dc.subject | Polymerase chain reaction -- Diagnostic use | en_ZA |
dc.title | Widespread use of incorrect PCR ramp rate negatively impacts multidrug-resistant tuberculosis diagnosis (MTBDRplus) | en_ZA |
dc.type | Article | en_ZA |